IDiyas

For the Inventor, By the Inventor

Pleasanton, CA, United States of America

Mark Lortz

USPTO Granted Patents = 14 

Average Co-Inventor Count = 7.0

ph-index = 10

Forward Citations = 1,266(Granted Patents)


Location History:

  • San Francisco, CA (US) (2012 - 2014)
  • Pleasanton, CA (US) (2006 - 2016)

Company Filing History:

goldMedal13 out of 1,353 
 
Abbott Diabetes Care Inc.
 patents
silverMedal1 out of 53 
 
Therasense, Inc.
 patents

Years Active: 2006-2016

Loading Chart...
14 patents (USPTO):Explore Patents
1. 9477811 - Blood glucose tracking apparatus and methods (2016-10-25),
2. 8765059 - Blood glucose tracking apparatus (2014-07-01),
3. 8529841 - Method for managing treatment of a particular health condition via a phone device (2013-09-10),
4. 8529840 - Method for collecting patient health condition management data at a central server system (2013-09-10),
5. 8529839 - Method for managing treatment of a particular health condition that includes graphing accumulated data (2013-09-10),
6. 8529838 - Method for managing treatment of a patient health condition with a PDA based system (2013-09-10),
7. 8273296 - System for managing treatment of a particular health condition via a mobile phone device (2012-09-25),
8. 8268243 - Blood glucose tracking apparatus and methods (2012-09-18),
9. 8257653 - Central server system for collecting patient health condition management data (2012-09-04),
10. 8257652 - System for managing treatment of a particular health condition that includes graphing accumulated data (2012-09-04),
11. 8236242 - Blood glucose tracking apparatus and methods (2012-08-07),
12. 8211364 - PDA based system for managing treatment of a patient health condition (2012-07-03),
13. 7976778 - Blood glucose tracking apparatus (2011-07-12),
14. 7041468 - Blood glucose tracking apparatus and methods (2006-05-09),

Title: Mark Lortz: Innovator in Blood Glucose Tracking Technology

Introduction

Mark Lortz is a notable inventor based in Pleasanton, California, with a significant contribution to the field of medical technology. He holds 14 patents, primarily focused on blood glucose tracking apparatus and methods. His innovations have played a crucial role in improving diabetes management for patients.

Latest Patents

Among his latest patents is a blood glucose tracking apparatus that features a measurement module for glucose testing. This apparatus includes a housing with a test strip receptacle and a connector portion designed for mechanical removable attachment to a hand-held computer. The electronics within the device determine the glucose levels present in a sample of body fluid when the test strip is positioned correctly. The results are then communicated to the hand-held computer via the connector portion, enhancing the ease of monitoring glucose levels.

Career Highlights

Mark Lortz has worked with prominent companies in the medical technology sector, including Abbott Diabetes Care Inc. and Therasense, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for glucose monitoring.

Collaborations

Throughout his career, Mark has collaborated with notable professionals in the field, including Steven H. Drucker and Charles T. Liamos. These collaborations have further enriched his work and led to advancements in glucose tracking technology.

Conclusion

Mark Lortz's contributions to blood glucose tracking technology have made a significant impact on diabetes management. His innovative patents and collaborations reflect his dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…